Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06051240
PHASE2

Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy

Sponsor: Region Stockholm

View on ClinicalTrials.gov

Summary

Randomized, placebo-controlled, double-blinded, parallel group clinical trial to investigate if 6 months of oral lithium tablets (S-lithium 0,5-1,0 mmol/l) will prevent cognitive decline after brain radiotherapy in pediatric brain tumor survivors. Primary outcome measure is Processing Speed Index (PSI) 2 years after start of study treatment.

Key Details

Gender

All

Age Range

5 Years - Any

Study Type

INTERVENTIONAL

Enrollment

84

Start Date

2024-02-16

Completion Date

2033-08-31

Last Updated

2024-04-12

Healthy Volunteers

No

Interventions

DRUG

Lithium

Lithium sulphate, 42 mg (6 mmol lithium)

DRUG

Placebo

White round tablet, 10 mm. Identical to experimental drug (lithium)

Locations (2)

Karolinska Universitetssjukhuset

Solna, Stockholm County, Sweden

HOPE

Stockholm, Sweden